Skip to main content
Premium Trial:

Request an Annual Quote

Plant Breeder to Use Keygene's Tools

NEW YORK (GenomeWeb News) – Keygene said today that it has signed a long-term contract with Semillas Fitó under which it will develop and integrate its molecular tools into the plant-breeding company's programs.

Keygene set the agreement through its InnovatorsClub, which is a collaboration platform for small and mid-sized plant breeding companies that gives them access to Keygene's molecular breeding technologies, software platforms, and experience. This agreement is the first in Keygene's new field crop consortium.

Barcelona-based Semillas Fitó plans to use the Keygene technologies to speed up its breeding processes and to lower costs and develop new plant varieties.

"This is an excellent opportunity to enhance our molecular biotech activities in Maize," explained Eduard Fitó, who is CEO of Semillas Fitó, in a statement. "Merging the current knowledge and expertise of both companies can give a lot of synergy to our crops."

Financial terms of the agreement were not released.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.